AMS at a Glance
Advanced Medical Solutions Group plc is a leading developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced woundcare markets.
Our primary focus is to create quality outcomes for our:
Full Year End31 December 2017
Interim Dividend Payment27 October 2017
Half Year End30 June 2017
Final Dividend Payment16 June 2017
Annual General Meeting7 June 2017
Preliminary Results Announcement14 March 2017
Advanced Medical Solutions Group plc is pleased to announce they have been awarded the Partnership with the NHS award at the Medilink North West... Read More
Latest Financial Highlights
AMS continues to perform well across the Group and is set to deliver another year of good growth and strong financial performance.
Good progress has been made with all of our brands. LiquiBand® continues to gain market share in the US, now at 24%, gaining 4% since June 2016. Our RESORBA® brands grew steadily across all territories and ActivHeal® reversed its decline and grew 9% to £3.1 million (2016 H1: £2.9 million).
We launched a number of new foam product ranges in the first half of 2016 through our OEM partners and, as previously guided, we have seen the effects of last year’s pipeline filling this year. Despite this effect, we are pleased to report that, sales in this Business Unit grew 6% at reported currency to £18.6 million (2016 H1: £17.5 million) and were unchanged at constant currency.
The Group continues to deliver a strong financial performance. Revenue increased by 17% to £45.9 million (2016 H1: £39.2 million) and by 8% at constant currency and adjusted profit before tax5 increased by 21% to £11.5 million (2016 H1: £9.5 million). Our net cash position as at 30 June 2017 was £55.2 million (31 December 2016: £51.1 million).
The Group continues to deliver solid results and is trading in line with Board expectations for the year ending 31 December 2017.